A Novel Coronavirus from Patients with Pneumonia in China, 2019 is a research paper published in New England Journal of Medicine (2020). On theSindex it has a DataRank of 1.5. It has been cited 21,793 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.5
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →FWCI
665.80
Citation Percentile
1.0%
Influential Citations
875
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 6 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 6 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 5 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 5 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 4 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 4 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 3 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 3 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 2 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 2 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 1 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 1 of The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)
Additional file 1 of Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2
Additional file 1 of Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2
Additional file 1 of Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study
Additional file 1 of Acute kidney injury in SARS-CoV2-related pneumonia ICU patients: a retrospective multicenter study
Additional file 1 of Mechanical transmission of SARS-CoV-2 by house flies
Additional file 1 of Mechanical transmission of SARS-CoV-2 by house flies
Additional file 2 of Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)
Additional file 2 of Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2)